Familial Hypercholesterolemia News and Research

RSS
Junk genes could one day offer framework for treating people with familial hypercholesterolemia

Junk genes could one day offer framework for treating people with familial hypercholesterolemia

PCSK9 Inhibitors: Highlights barriers to new, breakthrough cholesterol-lowering drugs

PCSK9 Inhibitors: Highlights barriers to new, breakthrough cholesterol-lowering drugs

Novel synthetic HDL-C injection shows no benefit on arterial plaques

Novel synthetic HDL-C injection shows no benefit on arterial plaques

UAB researchers developing new peptide that may help combat familial hypercholesterolemia

UAB researchers developing new peptide that may help combat familial hypercholesterolemia

Linking human genome sequences to EHR information could influence clinical medicine, says expert

Linking human genome sequences to EHR information could influence clinical medicine, says expert

Lipoprotein apheresis may have new role in patients with refractory angina

Lipoprotein apheresis may have new role in patients with refractory angina

PCSK9 inhibitor can reduce need for apheresis treatment in patients with familial hypercholesterolemia

PCSK9 inhibitor can reduce need for apheresis treatment in patients with familial hypercholesterolemia

First generic version of Crestor gets FDA approval

First generic version of Crestor gets FDA approval

Study demonstrates rarity of familial hypercholesterolemia mutations in individuals with high cholesterol

Study demonstrates rarity of familial hypercholesterolemia mutations in individuals with high cholesterol

PCSK9-inhibitor drugs: A game-changer for individuals with extremely high cholesterol levels

PCSK9-inhibitor drugs: A game-changer for individuals with extremely high cholesterol levels

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

Urine-derived iPSCs model could help predict patient response to cholesterol-lowering drugs

Urine-derived iPSCs model could help predict patient response to cholesterol-lowering drugs

Repatha (evolocumab) injection gets FDA approval for high cholesterol

Repatha (evolocumab) injection gets FDA approval for high cholesterol

Invitae announces dramatic expansion of genetic testing menu

Invitae announces dramatic expansion of genetic testing menu

Using deep learning to analyze genetic mutations: an interview with Brendan Frey

Using deep learning to analyze genetic mutations: an interview with Brendan Frey

New NIH grants support research that combines DNA sequence information and electronic medical records

New NIH grants support research that combines DNA sequence information and electronic medical records

Familial hypercholesterolemia patients can benefit from alirocumab drug

Familial hypercholesterolemia patients can benefit from alirocumab drug

Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

EMA's CHMP recommends approval of Praluent (alirocumab) for use in patients with hypercholesterolemia

EMA's CHMP recommends approval of Praluent (alirocumab) for use in patients with hypercholesterolemia